Fundraising Fox

Deepti Singh

Founder

Chief Scientific Officer & Co-founder at InGel Website

Boston, Massachusetts, United States

FoundedInGel Website

Find your path to Deepti

404 people in our graph share verified history with Deepti β€” schools, employers, funds. One of them is your warm intro.

About

Deepti Singh is the Founder and Chief Scientific Officer of InGel Therapeutics, Inc. She holds a Ph.D. focused on biomaterial-based tissue regeneration and has research experience at Yale and Harvard University, with specializations including ocular regeneration, biomaterials, polymer-based cell delivery, and stem cell therapies. Her current work involves the clinical translation of cell-based therapies for blinding diseases.

Chief Scientific Officer & Co-founder at InGel Website

Intro paths

β†’

In turn, Deepti can intro founders to InGel Website's investors below.

Co-founders at InGel Website

PJPatrick Jiang
Patrick JiangCEO & Co-founder
PC
Pierre Colombe DromelChief Technology Officer & Co-founder

Experience

  1. InGel Therapeutics, Inc.Founder and Chief Scientific Officercurrent2021 β€” presentUnited States
  2. Mass. Eye and EarResearch Fellow BE2018 β€” 2024Greater Boston Area
  3. Harvard Medical SchoolResearch Fellow2018 β€” 2024Greater Boston Area
  4. Yale School of MedicineAssociate Research Scientist2016 β€” 2018New Haven, Connecticut Area
  5. Yale School of MedicinePostdoctoral Research Associate2015 β€” 2016
  6. Yeungnam UniversityPostdoctoral Fellow/ International Research Professor2011 β€” 2014Gyeongsan, Gyeongsangbuk-do, Korea
  7. Indian Institute of Technology, KanpurResearch Fellow2008 β€” 2011Kanpur Area, India

Skills & more

Research10Science14Statistics4Molecular Biology13Cell Culture14PCR3Cell Biology3Data Analysis3Biochemistry7Western Blotting5Molecular Cloning3Genetics3
+10 morePolymerase Chain Reaction (PCR)Confocal MicroscopyLife SciencesMicroscopyBiotechnologyReal-Time Polymerase Chain Reaction (qPCR)MiceConfocal microscopyIn-vivoSub-retinal injection
  • Biomedical / Clinical Research Investigators β€” CITI Program
  • Fellows Responsible Conduct of Research β€” CITI Program
  • Conflicts of Interest β€” CITI Program
  • CITI Good Clinical Practice β€” CITI Program
  • MCB80.3x: Fundamentals of Neuroscience, Part 3: The Brain β€” HarvardX - An Online Learning Initiative by Harvard University through edX
  • Fundamentals of Neuroscience, Part 2: Neurons and Networks β€” HarvardX - An Online Learning Initiative by Harvard University through edX
  • Fundamentals of Neuroscience, Part 1: The Electrical Properties of the Neuron β€” HarvardX - An Online Learning Initiative by Harvard University through edX

From Deepti's professional profile.

Frequently asked questions

Who is Deepti Singh?
Deepti Singh is the Founder and Chief Scientific Officer of InGel Therapeutics, Inc. She holds a Ph.D. focused on biomaterial-based tissue regeneration and has research experience at Yale and Harvard University, with specializations including ocular regeneration, biomaterials, polymer-based cell delivery, and stem cell therapies. Her current work involves the clinical translation of cell-based therapies for blinding diseases.
Where does Deepti Singh work?
Deepti Singh is Chief Scientific Officer & Co-founder of InGel Website.
What companies did Deepti Singh found?
Deepti Singh founded InGel Website.
Where did Deepti Singh go to school?
Deepti Singh studied at Dr M G R Educational and Research Institute (Doctor of Philosophy (Ph.D.), Biotechnology/ Genetics); University of Madras (General Genetics/Immunology, Human/Medical Genetics); University of Madras (Microbiology, Microbiology).

Founder mafias

Same school

Shared employers